Detalhe da pesquisa
1.
The role of second autografts in the management of myeloma at first relapse.
Haematologica
; 91(1): 141-2, 2006 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-16434386
2.
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis.
Leuk Lymphoma
; 47(11): 2335-8, 2006 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17107906
3.
Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy.
Hematology
; 12(2): 113-5, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17454191
4.
Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft.
Hematology
; 10(5): 361-4, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-16203605
5.
Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.
Br J Haematol
; 129(5): 607-14, 2005 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15916682